selegiline has been researched along with Cerebrovascular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiguchi, I; Kimura, J; Nakamura, S | 1 |
| Hirokami, M; Minami, M; Parvez, H; Saito, H; Senjo, M; Yamazaki, N | 1 |
2 other study(ies) available for selegiline and Cerebrovascular Disorders
| Article | Year |
|---|---|
The histochemical demonstration of MPTP oxidation in the postmortem human striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Caudate Nucleus; Cerebrovascular Disorders; Clorgyline; Corpus Striatum; Dopamine Agents; Female; Glial Fibrillary Acidic Protein; Histocytochemistry; Humans; Male; Monoamine Oxidase; Neuroglia; Oxidation-Reduction; Putamen; Selegiline | 1993 |
Decreased monoamine oxidase activity in stroke-prone spontaneously hypertensive rat kidneys.
Topics: Animals; Cerebrovascular Disorders; Clorgyline; Hypertension; In Vitro Techniques; Kidney; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Selegiline | 1986 |